Yeast as a Model to Unravel Mechanisms Behind FUS Toxicity in Amyotrophic Lateral Sclerosis

Frontiers in Molecular Neuroscience
Michelle Lindström, Beidong Liu

Abstract

Fused in sarcoma (FUS) is a multifunctional DNA/RNA-binding protein predominantly localized in the cell nucleus. However, FUS has been shown to accumulate and form aggregates in the cytoplasm when mislocalized there due to mutations. These FUS protein aggregates are known as pathological hallmarks in a subset of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) cases. In this review, we discussed recent research developments on elucidating the molecular mechanisms behind FUS protein aggregation and toxicity. We mainly focus on studies using the budding yeast (Saccharomyces cerevisiae) as a model system, especially on results acquired from yeast genome-wide screens addressing FUS aggregation and toxicity. Human homologs of the FUS toxicity suppressors, identified from these studies, indicate a strong relevance and correlation to a human disease model. By using yeast as a FUS cytotoxicity model these studies provided valuable clues on potential novel targets for therapeutic intervention in ALS.

References

Mar 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·S Krobitsch, S Lindquist
Mar 20, 2002·Current Neurology and Neuroscience Reports·C E ShawN Leigh
Jun 12, 2002·The Journal of Cell Biology·Anatoli B MeriinMichael Y Sherman
Dec 6, 2003·Science·Tiago Fleming Outeiro, Susan Lindquist
Aug 10, 2004·The Journal of Biological Chemistry·Yuko IkoKosuke Morikawa
Jun 14, 2006·Briefings in Functional Genomics & Proteomics·Warren J LawGeoffrey G Hicks
Oct 3, 2006·Biochimica Et Biophysica Acta·Steffen PahlichHeinz Gehring
Dec 22, 2007·Neuro-Signals·James Shorter
Apr 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Brian S JohnsonAaron D Gitler
Jul 19, 2008·Biochimica Et Biophysica Acta·Piotr ZabrockiJoris Winderickx
Aug 6, 2008·Nature Reviews. Genetics·Olaf Isken, Lynne E Maquat
Nov 5, 2008·The Journal of Cell Biology·J Ross BuchanRoy Parker
Sep 22, 2009·Journal of Neurochemistry·Claudia ColombritaAntonia Ratti
Sep 29, 2009·Journal of Molecular Cell Biology·Adelene Y Tan, James L Manley
Oct 17, 2009·Brain Pathology·John WoulfeIan R A Mackenzie
Feb 5, 2010·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Shilpa VashistJames Shorter
Apr 2, 2010·Journal of Cell Science·Mimi CushmanJames Shorter
Apr 20, 2010·Human Molecular Genetics·Clotilde Lagier-TourenneDon W Cleveland
Jul 8, 2010·The EMBO Journal·Dorothee DormannChristian Haass
Aug 3, 2010·Neurobiology of Aging·Jozsef GalHaining Zhu
Aug 12, 2010·Human Molecular Genetics·Daryl A BoscoLawrence J Hayward
Dec 29, 2010·Biochemical and Biophysical Research Communications·Kun DuRiki Kurokawa
May 5, 2011·PLoS Biology·Shulin JuGregory A Petsko
Jun 28, 2011·Trends in Neurosciences·Dorothee Dormann, Christian Haass
Aug 19, 2011·Prion·Aaron D Gitler, James Shorter
Nov 15, 2011·Nature Structural & Molecular Biology·Jessica I HoellThomas Tuschl
Apr 23, 2013·Journal of Neurochemistry·Sandra TenreiroTiago F Outeiro

❮ Previous
Next ❯

Citations

Aug 13, 2020·International Journal of Molecular Sciences·Clara RuzSara Bandres-Ciga
Apr 11, 2019·Frontiers in Molecular Biosciences·Sigal Rencus-LazarDana Laor

❮ Previous
Next ❯

Methods Mentioned

BETA
protein folding
nuclear magnetic resonance
transgenic

Related Concepts

Related Feeds

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.